the Evaluation of the Efficacy of TCI66207 on the Skin.

TCI

Status: Completed

Conditions: Skin Diseases

Treatments: Dietary Supplement: TCI66207 Essence; Dietary Supplement: Placebo Essence

Study type: Interventional

Funder types: Industry

Identifiers

NCT05143034

TSMH No.18-148-A

Details and patient eligibility

About

The purpose of this study is to explore the evaluation of the efficacy of TCI66207 deep-sea live-face bacteria on the skin.

Enrollment: 40 patients

Sex: All

Ages: 20 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Healthy volunteers aged above 20 years old
2. Subject has dull skin.

Exclusion criteria

1. .Subject with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history).
2. Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
3. Female who is pregnant or nursing or planning to become pregnant during the course of the study.
4. Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks.
5. Subjects who have large spots (area >3 square centimeter) or abnormal acne.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

40 participants in 2 patient groups, including a placebo group

TCI66207 Essence

Experimental group

Description:

Essence

Treatment:

Dietary Supplement: TCI66207 Essence

Placebo Essence

Placebo Comparator group

Treatment:

Dietary Supplement: Placebo Essence